Depo-Provera: Popular Birth Control Under Legal Scrutiny
Depo-Provera, an injectable contraceptive administered every three months, has been a widely used birth control method for decades. Its convenience and effectiveness have made it a popular choice among women seeking long-term contraception.
However, recent studies have raised concerns about potential health risks associated with prolonged use of Depo-Provera. Notably, research published in The BMJ in March 2024 indicated that women who used Depo-Provera for over a year had a 5.6-fold increased risk of developing meningiomas, a type of brain tumor. These findings have prompted legal actions against Pfizer Inc., the manufacturer of Depo-Provera.
Legal Actions and Allegations
As of May 2025, over 130 lawsuits have been consolidated into a multidistrict litigation (MDL) in the United States. Plaintiffs allege that Pfizer failed to adequately warn users about the risk of developing meningiomas associated with Depo-Provera. While labels in the European Union and Canada have included warnings about this risk, U.S. labels have not been updated to reflect these concerns.
One notable case involves a Utah woman who used Depo-Provera from 1996 to 2006 and was later diagnosed with a Grade II-III intracranial meningioma at the age of 31.
Understanding Meningiomas
Meningiomas are tumors that form on the membranes covering the brain and spinal cord. While often benign, they can cause serious health issues, including headaches, vision problems, and neurological deficits. Treatment may involve surgery or radiation therapy, depending on the tumor’s size and location.
What This Means for You
If you or someone you know has used Depo-Provera and experienced symptoms such as persistent headaches, vision changes, or other neurological issues, it’s crucial to consult a healthcare professional. Early detection and treatment of meningiomas can significantly improve outcomes.
Additionally, individuals affected by these issues may have legal options. Consulting with an attorney experienced in pharmaceutical litigation can help determine eligibility for compensation related to medical expenses, lost wages, and other damages.